Follow for more talkers

Study finds rhubarb could help fight antibiotic-resistant superbugs

In addition to rhubarb, researchers say turmeric can also help combat bacteria.

Avatar photo

Published

on
(Photo by Magda Ehlers via Pexels)

By Stephen Beech

Rhubarb could help battle deadly antibiotic-resistant superbugs such as E. coli, suggests new research.

Natural compounds from the edible plant as well as the spice turmeric, showed "promise" in fighting off several antibiotic-resistant bacteria lurking in wastewater, say scientists.

They explained that when people are taking antibiotics, some of the dose is excreted with urine and poo and ends up in our wastewater.

The presence of low doses of antibiotics creates a chance for resistant bacteria to evolve.

American researchers studying antibiotic resistant bacteria in wastewater at a treatment plant discovered multi-drug resistant strains of bacteria species which are usually not dangerous to healthy people, but which could transmit genes for antibiotic resistance to much more dangerous bacteria such as E. coli.

The team challenged the bacteria with natural compounds which could potentially be included in wastewater treatment to kill off bacteria and fight antibiotic resistance.

The most effective were emodin, from comes from rhubarb, and curcumin, from turmeric, according to the findings published in the journal Frontiers in Microbiology.

Study senior author Dr. Joanna Hou, of Utah State University, said: “Without improved treatment, wastewater could serve as a breeding ground for ‘superbugs’ that may enter water resources such as rivers, lakes, and reservoirs, posing potential risks to public health.

“Our goal was to isolate and characterize multidrug-resistant bacteria, explore the molecular mechanisms of resistance through whole-genome sequencing, and assess the potential of natural compounds as alternative mitigation strategies.”

She explained that antibiotic resistance develops when bacteria evolve to be less vulnerable to antibiotics.

It is more likely to happen if bacteria are exposed to a dose of vaccine that is too low to kill them all as the survivors develop resistance.

(Photo by Caleb Rankin via Unsplash)

Someone infected with the resistant bacteria may then find that their treatment doesn’t work, potentially making routine surgery or illness much more dangerous.

Some bacteria are resistant to several antibiotics, and those infections are often treated with "last resort" drugs such as colistin.

But when Dr. Hou and her colleagues tested samples of effluent from a wastewater treatment plant in Logan, Utah, they found some colonies of bacteria that were resistant even to colistin.

They say that this underlines the urgency of finding ways of preventing and treating bacterial infection which minimize the use of antibiotics.

The research team screened their samples using one antibiotic, sulfamethoxazole, to identify nine different antibiotic-resistant strains.

The strains of bacteria were then tested against multiple classes of antibiotics to see how many they resisted.

Their genomes were also sequenced, which allowed the research team to identify not just the bacteria themselves but genes which contribute to their antibiotic resistance.

One strain, U2, which had the highest number and variety of antibiotic resistance genes, was resistant to all the antibiotics tested.

The strains represented species of Microbacterium, Chryseobacterium, Lactococcus lactis, and Psychrobacter.

Dr. Hou said: “While not traditionally classified as top-priority clinical pathogens, some are opportunistic pathogens associated with infections such as pneumonia in immunocompromised individuals.

“These bacteria could also act as environmental reservoirs, transferring resistance genes to other bacteria, including clinically relevant pathogens.”

(Photo by Maximilian Zahn via Unsplash)

The team challenged colonies of the bacteria with different concentrations of 11 natural compounds.

They then looked at different measurements of the colonies’ health including cell growth, biofilm formation, and how active the bacteria were.

Dr. Hou said: “We selected a panel of compounds primarily derived from plants, such as curcumin from turmeric, quercetin from onions and apples, and emodin from rhubarb.

“These compounds were chosen based on their reported antimicrobial or anti-biofilm properties in previous studies and their natural abundance, making them promising candidates for exploring new, environmentally friendly approaches to mitigate resistance.”

The team found that emodin and curcumin were best at inhibiting cell growth and biofilm formation, while curcumin and a higher dose of emodin reduced cell activity - although a low dose of emodin increased activity for several strains.

But Gram-negative bacteria, such as Chryseobacterium, were resistant to all the compounds.

Dr. Hou said: “While natural compounds like curcumin and emodin show promise in inhibiting Gram-positive multidrug-resistant bacteria, further research is needed."

She added: “Future work should include testing these compounds in complex wastewater matrices, exploring synergistic effects with existing treatment processes, and assessing long-term impacts on microbial communities and resistance dynamics.

"Additionally, scaling up from laboratory studies to pilot-scale trials will be critical for evaluating feasibility and environmental safety.”

Stories and infographics by ‘Talker Research’ are available & ready to use. Stories and videos by ‘Talker News’ are managed by Talker Inc. For queries, please submit an inquiry via our contact form.

Top Talkers